ReviewJournal of Cancer2024

Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy.

Han Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.